ANTI-ANGINAL EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETIC AND REFRACTORY ANGINA; A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (EMPT-ANGINA TRIAL)

(2023) ANTI-ANGINAL EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETIC AND REFRACTORY ANGINA; A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (EMPT-ANGINA TRIAL). Atherosclerosis. p. 1. ISSN 0021-9150

Full text not available from this repository.

Item Type: Article
Keywords: Cardiovascular System & Cardiology
Page Range: p. 1
Journal or Publication Title: Atherosclerosis
Journal Index: ISI
Volume: 379
ISSN: 0021-9150
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/27387

Actions (login required)

View Item View Item